...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Good luck!

Still, Noted as N/A ( Not available?) 82 out of 91 entries:

List of COVID-19 treatment trials

https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/list-authorized-trials.html#wb-auto-5

 

RVX222-CS-023
(Control # 250480)
An Open-Label Study to Assess the Safety and Effect on Clinical Course and Key Biomarkers of Oral Apabetalone in Hospitalized Subjects with COVID-19 Infection in Addition to Standard of Care (SOC) RVX000222 (Apabetalone) Resverlogix Corp 2021-04-06 N/A

 

 

Koo

Share
New Message
Please login to post a reply